Joseph Jr. Manko Buys 170,830 Shares of Myomo (NYSEAMERICAN:MYO) Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Joseph Jr. Manko purchased 170,830 shares of the firm’s stock in a transaction on Thursday, May 14th. The stock was acquired at an average price of $0.86 per share, with a total value of $146,913.80. Following the completion of the purchase, the director owned 2,279,408 shares of the company’s stock, valued at $1,960,290.88. The trade was a 8.10% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Myomo Trading Up 4.7%

Myomo stock opened at $0.88 on Wednesday. The stock has a 50-day moving average of $0.77 and a two-hundred day moving average of $0.84. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.36 and a current ratio of 2.73. Myomo, Inc. has a one year low of $0.61 and a one year high of $3.45. The stock has a market cap of $33.93 million, a PE ratio of -2.44 and a beta of 1.39.

Analyst Upgrades and Downgrades

Separately, Craig Hallum reissued a “buy” rating on shares of Myomo in a report on Tuesday, March 10th. Four investment analysts have rated the stock with a Buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $7.67.

Institutional Trading of Myomo

Several hedge funds and other institutional investors have recently bought and sold shares of MYO. Rosalind Advisors Inc. grew its holdings in Myomo by 33.0% during the second quarter. Rosalind Advisors Inc. now owns 3,595,788 shares of the company’s stock worth $7,767,000 after acquiring an additional 892,127 shares during the period. Jefferies Financial Group Inc. acquired a new stake in Myomo during the fourth quarter worth about $641,000. Geode Capital Management LLC grew its holdings in Myomo by 160.8% during the second quarter. Geode Capital Management LLC now owns 669,281 shares of the company’s stock worth $1,446,000 after acquiring an additional 412,631 shares during the period. Centiva Capital LP acquired a new stake in Myomo during the third quarter worth about $190,000. Finally, Prescott Group Capital Management L.L.C. acquired a new stake in Myomo during the fourth quarter worth about $169,000. 44.99% of the stock is owned by institutional investors and hedge funds.

About Myomo

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.